ScreenerHero

WAVE Waverley Pharma Inc.

TSXV · CA · Healthcare · Biotechnology · waverleypharma.com
0.0100CAD0.00%Mkt Cap: 393261 $P/E: —

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a ret…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap393.26K USD
Enterprise Value2.99M USD
Revenue (TTM)855.17K USD
Gross Profit374.09K USD
Net Income (TTM)-363.56K USD
Revenue/Share0.02 CAD
Last Price0.0100 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA94357L1058
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.14
EV/Revenue3.49
P/S0.46
P/B-0.20
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.01000% of range0.0400
52W High0.0400 CAD
52W Low0.0100 CAD
Profitability
Gross Margin38.06%
Oper. Margin-31.12%
EBITDA Margin-42.90%
Profit Margin-36.99%
ROE19.42%
ROA-40.12%
Growth
Revenue Growth-18.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-444.99K USD
CapEx (TTM)—
FCF Margin-8.93%
FCF Yield-19.42%
Net Debt2.59M USD
Net Debt/EBITDA-7.07
Balance Sheet
Debt/Equity-1.34
Current Ratio0.09
Quick Ratio0.02
Book Value/Sh-0.05 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.00M
Float13.55M
Insiders74.90%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short111
Short (prev mo.)39
Technical
SMA 500.0140 (-28.6%)
SMA 2000.0169 (-40.7%)
Beta1.46
S&P 52W Chg16.45%
Avg Vol (30d)1.90K
Avg Vol (10d)0
Technical Indicators
RSI (14)27.8
MACD-0.0016
MACD Signal-0.0016
MACD Hist.-0.0000
BB Upper0.0194 CAD
BB Middle0.0125 CAD
BB Lower0.0056 CAD
BB Width110.12%
ATR (14)0.0005 CAD
Vol Ratio (20d)0.36x